The Power of Innovation
Study shows immunotherapy may lower recurrence of advanced melanoma
June 20, 2024
Monte Shaheen, MD, a melanoma expert at Mays Cancer Center, was part of a team of investigators that conducted a phase 2 clinical trial funded by the National Cancer Institute. The study showed that participants with stage 3 or stage 4 melanoma who were given pembrolizumab before and after surgery had significantly lower risks of recurring cancer.
CPRIT awards nearly $8M for research infrastructure
June 20, 2024
The Cancer Prevention and Research Institute of Texas (CPRIT) announced two awards totaling nearly $8 million to support research infrastructure at The University of Texas Health Science Center at San Antonio. Two core research facilities at UT Health San Antonio’s Greehey Children’s Cancer Research Institute will be expanded. A $3.9 million CPRIT award enhances the […]
New hospital will bring advanced research and patient care under one roof
June 20, 2024
“This will be a world-class facility with technology and ambience backing up superb medical teams.” – William L. Henrich, MD, MACP, former president, UT Health San Antonio, October 2022 Surgeries in multiple specialties, new services for the region — including cellular therapies, such as stem cell transplants and CAR T-cell therapy — and access to […]